Saturday, August 06, 2022 6:38:02 PM
C4urself the 1st Ammendment.
Don't assume that i don't know, and i wont assume, that you have no idea.
Recent QNCX News
- Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference • Business Wire • 05/06/2024 08:05:00 PM
- Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results • Business Wire • 04/01/2024 11:00:00 AM
- Quince Therapeutics Launches Scientific Advisory Board • Business Wire • 02/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:00:43 PM
- Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors • Business Wire • 02/15/2024 12:00:00 PM
- Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference • Business Wire • 02/07/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:53:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:01:33 PM
- Quince Therapeutics to Participate at Investor Events in January 2024 • Business Wire • 01/04/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:02:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 11:21:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:06:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 11:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 06:38:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 09:54:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 11:42:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 11:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:05:58 PM
- Quince Therapeutics Completes Acquisition of EryDel S.p.A. • Business Wire • 10/23/2023 11:00:00 AM
- Quince Therapeutics to Advance Study of EryDex as FDA Lifts Application Hold • Dow Jones News • 09/28/2023 08:53:00 PM
- U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia • Business Wire • 09/28/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 11:18:03 AM
- Quince Therapeutics Appoints Dr. Charles S. Ryan as President • Business Wire • 09/06/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2023 10:42:15 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM